検索結果一覧

一般口演 / Oral Session

【E】一般口演 19 (Oral Session 19) :AML:Mechanism of Therapeutic Agent
 
日程
2013年10月11日(金)
時間
14:25 - 15:25
会場
第4会場 / Room No.4 (さっぽろ芸文館 3F 黎明)
座長・司会
小林 正夫 (Masao Kobayashi):1
1:Department of Pediatrics, Graduate School of Biomedical & Health Sciences, Hiroshima University, Japan

前へ戻る


A novel STAT inhibitor, OPB-31121, has a significant anti-tumor effect on STAT-dependent leukemia

演題番号 : OS-1-95

早川 文彦 (Fumihiko Hayakawa):1、杉本 慶樹 (Keiki Sugimoto):2,3、倉橋 信悟 (Shingo Kurahashi):4、直江 知樹 (Tomoki Naoe):5

1:Nagoya Univ. Hosp., Dept. Hematology, Nagoya, Japan、2:Nagoya Univ. Dept. Hematology and Oncology, Nagoya, Japan、3:Fujii Memorial Res. Ins., Otsuka Pharma. Co. Ltd., Otsu, Japan、4:Nagoya First Red Cross Hosp., Dept. Hematology, Nagoya, Japan、5:Nagoya Medical Center, Nagoya, Japan

A novel STAT inhibitor, OPB-31121, has a significant anti-tumor effect on STAT-dependent leukemia

Downstream targets of FLT3-ITD in Ara-C resistance of leukemic cells

演題番号 : OS-1-96

Anar Damdinsuren:1、松下 弘道 (Hiromichi Matsushita):1、Masatoshi Ito:2、Masatoshi Ito:2、Hideo Tsukamoto:2、Masayuki Tanaka:2、松澤 秀之 (Hideyuki Matsuzawa):2、Satomi Asai:1、安藤 潔 (Kiyoshi Ando):3、宮地 隼人 (Hayato Miyachi):1

1:Department of Laboratory Medicine, Tokai University, School of Medicine, Japan、2:Education and Research Support Center, Tokai University, School of Medicine、3:Department of Hematology and Oncology, Tokai University, School of Medicine

Downstream targets of FLT3-ITD in Ara-C resistance of leukemic cells

Inhibitory effects of FL on proliferation and FLT3 inhibitors in Wt- and ITD-FLT3-coexpressing cells

演題番号 : OS-1-97

陳 昉里 (Fangli Chen):1、中谷 俊幸 (Toshiyuki Nakatani):1、木原 里香 (Rika Kihara):1、直江 知樹 (Tomoki Naoe):1、清井 仁 (Hitoshi Kiyoi):1

1:Department of Hematology/Oncology, Nagoya University Graduate School of Medicine, Japan

Inhibitory effects of FL on proliferation and FLT3 inhibitors in Wt- and ITD-FLT3-coexpressing cells

A novel proteasome independent target of bortezomib in leukemia cells

演題番号 : OS-1-98

Chun-Yu Liu (劉 峻宇):1、Chung-Wai Shiau:2、Kuen-Feng Chen:3、Hsin-Yu Kuo:1、Hui-Chuan Yu:3、Hsiang-Po Huang:3、Cheng-Hwai Tzeng:1、Po-Min Chen:1

1:Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan、2:Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan、3:Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan

A novel proteasome independent target of bortezomib in leukemia cells

Efficacy and biomarker analyses of treatment with the Hedgehog inhibitor, PF-04449913, in AML cells

演題番号 : OS-1-99

福島 庸晃 (Nobuaki Fukushima):1、南 陽介 (Yosuke Minami):2、直江 知樹 (Tomoki Naoe):1

1:Dept of Hematology and Oncology, Nagoya Univ、2:Division of Blood Transfusion / Division of Oncology and Hematology, Kobe Univ Hospital

Efficacy and biomarker analyses of treatment with the Hedgehog inhibitor, PF-04449913, in AML cells